Status: Enacted
Year Enacted: 2016
Governs PBM cost transparency requirements.
Status: Enacted
Year Enacted: 2000
Allows pharmacists to substitute generics. Must disclose price difference to consumer if they choose not to substitute.
Cal. Bus. & Prof. Code §§ 4050 through 4068: Pharmacy — Scope of Practice and Exemptions – California
Status: Enacted
Year Enacted: 1996
Notwithstanding any other law, a pharmacist may authorize the initiation of a prescription, pursuant to Section 4052.1, 4052.2, 4052.3, or 4052.6, and otherwise provide clinical advice, services, information, or patient consultation, as set forth in […]
Status: Enacted
Year Enacted: 2018
A consumer has the right to know about any options they have to reduce costs of drugs at a pharmacy. This act mandates that pharmacies provide information about the price of perscription drugs.
D.C. Code § 48-855.01. Definitions: Specialty Drug Copayment Limitation – District of Columbia
Status: Enacted
Year Enacted: 2017
Definitions of relevant network provider and asepects of benefit design in D.C. health care system.
D.C. Code § 48-855.02. Specialty drug copayment or coinsurance limitation: Specialty Drug Copayment Limitation – District of Columbia
Status: Enacted
Year Enacted: 2017
A health benefit plan that provides coverage for prescription drugs shall ensure that a required copayment or coinsurance applicable to a drug on a specialty tier does not exceed $150 per month for up to […]
Status: Enacted
Year Enacted: 2018
A contract between a pharmacy benefits manager and a pharmacy may not prohibit a pharmacy or pharmacist from doing any of the following.
Status: Enacted
Year Enacted: 1992
“Practice of pharmacy” means the interpreting, evaluating, and dispensing of a practitioner’s or prescriber’s order. The practice of pharmacy includes, but is not limited to, the proper compounding, labeling, packaging, and dispensing of a drug […]
Status: Enacted
Year Enacted: 2017
A pharmacy benefits manager shall be proscribed from prohibiting a pharmacist or pharmacy from providing an insured individual information on the amount of the insured’s cost share for such insured’s prescription drug and the clinical […]
Status: Enacted
Year Enacted: 1980
A pharmacy benefit manager that reimburses a contracting pharmacy for a drug on a maximum allowable cost basis shall comply with the requirements of this section. (b) The pharmacy benefit manager shall include the following […]
Status: Enacted
Year Enacted: 2018
A licensed prescriber may authorize a pharmacist to substitute a drug with another drug in the same therapeutic class that would, in the opinion of the pharmacist, have a substantially equivalent therapeutic effect even though […]
Status: Enacted
Year Enacted: 2007
The commissioner may require a pharmacy benefits manager to submit information to the commissioner related to the pharmacy benefits manager’s pricing methodology for maximum reimbursement amount.
Status: Enacted
Year Enacted: 1990
The secretary of health and environment shall implement a drug utilization review program with the assistance of a medicaid drug utilization review board as provided in K.S.A. 39-7,119, and amendments thereto, to assure the appropriate […]
Status: Enacted
Year Enacted: 1998
A managed care plan shall include a drug utilization review program. A managed care plan that restricts pharmacy benefits to a drug formulary shall have an exceptions policy through which the managed care plan may […]
Status: Enacted
Year Enacted: 2008
A pharmacy benefits manager shall register with the Commissioner as a pharmacy benefits manager before providing pharmacy benefits management services in the State to purchasers. Form of application and fee
Status: Enacted
Year Enacted: 2008
In any therapeutic interchange solicitation, the following shall be disclosed to the prescriber: that a therapeutic interchange is being solicited, the circumstances under which the originally prescribed drug will be covered by the purchaser, the […]
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.